Article Versions Notes

Faille D, Lamrani L, Loyau S, Huisse M-G, Bourrienne M-C, Alkhaier S, Cassinat B, Boulaftali Y, Debus J, Jandrot-Perrus M, et al. Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms. Cancers. 2020; 12(4):992. https://doi.org/10.3390/cancers12040992

Faille, Dorothée, Lamia Lamrani, Stéphane Loyau, Marie-Geneviève Huisse, Marie-Charlotte Bourrienne, Sawsaneh Alkhaier, Bruno Cassinat, Yacine Boulaftali, Jérôme Debus, Martine Jandrot-Perrus, and et al. 2020. "Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms" Cancers 12, no. 4: 992. https://doi.org/10.3390/cancers12040992

Faille, D., Lamrani, L., Loyau, S., Huisse, M.-G., Bourrienne, M.-C., Alkhaier, S., Cassinat, B., Boulaftali, Y., Debus, J., Jandrot-Perrus, M., Chomienne, C., Dosquet, C., & Ajzenberg, N. (2020). Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms. Cancers, 12(4), 992. https://doi.org/10.3390/cancers12040992